ଫୁସଫୁସ କ୍ୟାନ୍ସର (ନନ୍-ସ୍ମଲ୍ ସେଲ୍)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
କେଉଁଠିକୁ ଯିବେ
ଏହି trial ପାଇଁ ଭାରତରେ ୬ଟି hospital ରୋଗୀଙ୍କୁ ନେଉଛନ୍ତି.
ରେଜିଷ୍ଟ୍ରି ସାରାଂଶ (ଟେକ୍ନିକାଲ୍)
The purpose of this study is to understand if PF-08046054 alone works well compared to standard-of-care docetaxel alone in participants with non-small cell lung cancer (NSCLC) with PD-L1 expression greater than or equal to 1% and had cancer progression during or after treatment with PD-L1 or PD-1 inhibitors, platinum-based chemotherapy, and targeted treatment regimen(s) for participants with known actionable genomic alterations (AGAs). Participants in this study must have cancer that has spread through their body or can't be removed with surgery or treated with definitive radiation. Participa…
ସ୍ପୋନ୍ସର: Pfizer
ClinicalTrials.gov ରେ NCT07144280
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 13 Oct 2026 · ଆମ ଦ୍ୱାରା ପଢ଼ାଯାଇଛି 20 Oct 2026